Gadobenate dimeglumine-enhanced magnetic resonance angiography of the pelvic arteries

Investigative Radiology

Volumn 38, Issue 8, 2003, Pages 504-515

  Wikström, Johan ^a   Wasser, Martin N ^b   Pattynama, Peter M T ^c   Bonomo, Lorenzo ^d   Hamm, Bernd ^e   Del Maschio, Alessandro ^f   Knopp, Michael V ^g   Marchal, Guy ^h   Barentsz, Jelle O ^c   Oudkerk, Matthijs ⁱ   Hentrich, Hans Rainer ^j   Daprà, Massimo ^k   Kirchin, Miles A ^k   Shen, Ningyan ^l   Spinazzi, Alberto ^l   Ahlström, Håkan ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Formazione dell'Immagine   (Italy)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j ALTANA PHARMA AG   (Germany)

^k Bracco Imaging SpA   (Italy)

^l Bracco Research USA   (United States)

more..

Author keywords

Contrast media; Gadobenate dimeglumine; Gd BOPTA; Iliac artery; Magnetic resonance angiography; Phase II clinical trial

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; ELECTROCARDIOGRAM; FEMALE; HUMAN; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PELVIS ANGIOGRAPHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT;

EID: 10744225127     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000074585.46615.2e     Document Type: Article

References (33)

1. Prince MR. Gadolinium-enhanced MR aortography. Radiology. 1994; 191:155-164.
2. Prince MR, Narasimham DL, Stanley JC, et al. Gadolinium-enhanced magnetic resonance angiography of abdominal aortic aneurysms. J Vase Surg. 1995;21:656-669.
3. Steiner P, McKinnon GC, Romanowski B, et al. Contrast-enhanced, ultrafast 3D pulmonary MR angiography in a single breath-hold: initial assessment of imaging performance. J Magn Reson Imaging. 1997;7: 177-182.
4. Hany TF, Debatin JF, Leung DA, et al. Evaluation of the aortoiliac and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology. 1997;204:357-362.
5. Wikström J, Holmberg A, Johansson L, et al. Gadolinium-enhanced magnetic resonance angiography, digital subtraction angiography and duplex of the iliac arteries compared with intra-arterial pressure gradient measurements. Eur J Vasc Endovasc Surg. 2000;19:516-523.
6. Snidow JJ, Aisen AM, Harris VJ, et al. Iliac artery MR angiography: comparison of three-dimensional gadolinium-enhanced and two-dimensional time-of-flight techniques. Radiology. 1995;196:371-378.
7. Poon E, Yucel EK, Pagan-Marin H, et al. Iliac artery stenosis measurements: comparison of two-dimensional time-of-flight and three-dimensional dynamic gadolinium-enhanced MR angiography. AJR Am J Roentgenol. 1997;169:1139-1144.
8. Willig DS, Turski PA, Frayne R, et al. Contrast-enhanced 3D MR DSA of the carotid artery bifurcation: preliminary study of comparison with unenhanced 2D and 3D time-of-flight MR angiography. Radiology. 1998;208:447-451.
9. Sardanelli F, Zandrino F, Parodi RC, et al. MR angiography of internal carotid arteries: breath-hold Gd-enhanced 3D fast imaging with steady-state precession versus unenhanced 2D and 3D time-of-flight techniques. J Comput Assist Tomogr. 1999;23:208-215.
10. Lorenz CH, Johansson LO. Contrast-enhanced coronary MRA. J Magn Reson Imaging. 1999;10:703-708.
11. Leclerc X, Gauvrit JY, Nicol L, et al. Contrast-enhanced MR angiography of the craniocervical vessels: a review. Neuroradiology. 1999;41: 867-874.
12. Parker DL, Tsuruda JS, Goodrich KC, et al. Contrast-enhanced magnetic resonance angiography of cerebral arteries. A review. Invest Radiol. 1998;33:560-572.
13. Kouwenhoven M. Contrast-enhanced MR angiography. Methods, limitations and possibilities. Acta Radiol. 412(Suppl 1):S57-S67, 1997.
14. de Haën C, Cabrini M, Akhnana L, et al. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr. 1999;23(Suppl 1):S161-S168.
15. Spinazzi A, Lorusso V, Pirovano G, et al. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol. 1999;6:282-291.
16. Kirchin MA, Pirovano G, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA). An overview. Invest Radiol. 1998;33:798-809.
17. Knopp MV, Schoenberg SO, Rehm C, et al. Assessment of gadobenate dimeglumine (Gd-BOPTA) for MR angiography: Phase I studies. Invest Radiol. 2002;37:706-715.
18. Völk M, Strotzer M, Lenhart M, et al. Renal time-resolved MR angiography: quantitative comparison of gadobenate dimeglumine and gadopentetate dimeglumine with different doses. Radiology. 2001;220:484-488.
19. Herbom C, Lauenstein T, Ruehm S, et al. Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine and gadobutrol for pelvic 3D magnetic resonance angiography. Invest Radiol. 2003;38: 27-33.
20. Knopp MV, Giesel FL, von Tengg-Kobligk H, et al. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging. 2003;17:694-702.
21. Kroencke TJ, Wasser MN, Pattynama PMT, et al. Gadobenate dimeglumine - enhanced magnetic resonance angiography of the abdominal aorta and renal arteries. AJR Am J Roentgenol. 2002;179:1573-1582.
22. Kirchin MA, Pirovano G, Venetianer C, et al. Safety assessment of gadobenate dimeglumine (Multihancet): extended clinical experience from phase I studies to post-marketing surveillance. J Magn Reson Imaging. 2001;14:281-294.
23. Johansson LO, Ahlström HK. Correlation between dose rate and T1 in blood at Gd-enhanced MR angiography. Acta Radiol. 1998;39:579-582.
24. Carroll TJ, Korosec FR, Swan JS, et al. The effect of injection rate on time-resolved contrast-enhanced peripheral MRA. J Magn Reson Imaging. 2001;14:401-10.
25. Ruehm SG, Goyen M, Barkhausen J, et al. Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet. 2001;357:1086-1091.
26. Elgersma OE, Wust AF, Buijs PC, et al. Multidirectional depiction of internal carotid arterial stenosis: three-dimensional time-of-flight MR angiography versus rotational and conventional digital subtraction angiography. Radiology. 2000;216:511-516.
27. von Tengg-Kobligk H, Floemer F, Knopp MV. Multiphasic MR angiography as an intra-individual comparison between the contrast agents Gd-DTPA, Gd-BOPTA, and Gd-BT-DO3A [in German]. Radiologe. 2003;43:171-178.
28. Goyen M, Herborn CU, Lauenstein TC, et al. Optimization of contrast dosage for gadobenate dimeglumine-enhanced high-resolution whole body 3D MR Angiography. Invest Radiol. 2002;37:263-268.
29. Goyen M, Quick HH, Debatin JF, et al. Whole-body three-dimensional MR angiography with a rolling table platform: initial clinical experience. Radiology. 2002;224:270-7.
30. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol. 1997;32:780-796.
31. Kroft LJ, de Roos A. Blood pool contrast agents for cardiovascular MR imaging. J Magn Reson Imaging. 1999;10:395-403.
32. Engelbrecht MR, Saeed M, Wendland MF, et al. Contrast-enhanced 3D-TOF MRA of peripheral vessels: intravascular versus extracellular MR contrast media. J Magn Reson Imaging. 1998;8:616-621.
33. Stillman AE, Wilke N, Li D, et al. Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: studies in human patients. J Comput Assist Tomogr. 1996;20:51-55.